25 related articles for article (PubMed ID: 19191807)
1. Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients.
Newland DM; Pak JL; Ali R; Herzog T; Nemeth TL; Tressel W; Kronmal RA; Knorr LR; Albers EL; Friedland-Little JM; Ahmed H; Kemna MS; Hong BJ; Spencer K; Law YM
Clin Transplant; 2023 Nov; 37(11):e15087. PubMed ID: 37526562
[TBL] [Abstract][Full Text] [Related]
2. Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling.
Rong Y; Wichart J; Hamiwka L; Kiang TKL
Clin Pharmacokinet; 2023 Sep; 62(9):1289-1303. PubMed ID: 37493886
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimicrobial activity of amino acid and peptide derivatives of mycophenolic acid.
Siebert A; Wysocka M; Krawczyk B; Cholewiński G; Rachoń J
Eur J Med Chem; 2018 Jan; 143():646-655. PubMed ID: 29216563
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.
Abd Rahman AN; Tett SE; Staatz CE
Clin Pharmacokinet; 2013 May; 52(5):303-31. PubMed ID: 23475567
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.
Baudouin V; Alberti C; Lapeyraque AL; Bensman A; André JL; Broux F; Cailliez M; Decramer S; Niaudet P; Deschênes G; Jacqz-Aigrain E; Loirat C
Pediatr Nephrol; 2012 Mar; 27(3):389-96. PubMed ID: 21947272
[TBL] [Abstract][Full Text] [Related]
6. Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.
van Hest RM; Mathot RA; Vulto AG; Ijzermans JN; van Gelder T
Ther Drug Monit; 2006 Feb; 28(1):31-4. PubMed ID: 16418690
[TBL] [Abstract][Full Text] [Related]
7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
8. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
Pape L; Ehrich JH; Offner G
Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
Huang HF; Yao X; Chen Y; Xie WQ; Shen-Tu JZ; Chen JH
Int J Clin Pract Suppl; 2014 Apr; (181):4-9. PubMed ID: 24673713
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables.
Ghio L; Ferraresso M; Zacchello G; Murer L; Ginevri F; Belingheri M; Peruzzi L; Zanon F; Perfumo F; Berardinelli L; Tirelli S; Dello Strologo L; Fontana I; Valente U; Cardillo M; Edefonti A
Clin Transplant; 2009; 23(2):264-70. PubMed ID: 19191807
[TBL] [Abstract][Full Text] [Related]
13. Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation.
Filler G
Pediatr Transplant; 2006 Sep; 10(6):707-11. PubMed ID: 16911495
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
